Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Public ClinicalTrials.gov record NCT05635266. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Single-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To collect, preserve, and/or distribute annotated biospecimens and associated medical data to institutionally approved, investigator-directed biomedical research to discover and develop new treatments, diagnostics, and preventative methods for specific and complex conditions.
Study identification
- NCT ID
- NCT05635266
- Recruitment status
- Not listed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 20,000 participants
Conditions and interventions
Conditions
- Age-Related Macular Degeneration
- Allergies
- Alpha-Gal Syndrome
- Alzheimer Disease
- Amyloidosis
- Ankylosing Spondylitis
- Arthritis
- Alopecia Areata
- Asthma
- Atopic Dermatitis
- Autism
- Autoimmune Hepatitis
- Behcet's Disease
- Beta-Thalassemia
- Cancer
- Celiac Disease
- Kidney Diseases
- COPD
- Crohn Disease
- Cystic Fibrosis
- Diabetes
- Dravet Syndrome
- DMD
- Fibromyalgia
- Graves Disease
- Thyroid Diseases
- Hepatitis
- Hidradenitis Suppurativa
- ITP
- Leukemia
- ALS
- Lupus or SLE
- Lymphoma
- Multiple Sclerosis
- Myasthenia Gravis
- Heart Diseases
- Parkinson Disease
- Pemphigus Vulgaris
- Cirrhosis
- Psoriasis
- Schizophrenia
- Scleroderma
- Sickle Cell Disease
- Stroke
- Ulcerative Colitis
- Vasculitis
- Vitiligo
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 25, 2021
- Primary completion
- Sep 30, 2025
- Completion
- Sep 30, 2025
- Last update posted
- May 6, 2024
2021 – 2025
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sanguine Biosciences | Waltham | Massachusetts | 02451 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05635266, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 6, 2024 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05635266 live on ClinicalTrials.gov.